U.S. Clinical Trials Market Trends Regulations And Competitive Landscape Outlook to 2030

 

U.S. Clinical Trials Market Growth & Trends

The U.S. clinical trials market size is expected to reach USD 36.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 5.4% from 2022 to 2030. The increasing prevalence of chronic disease and growing demand for clinical trials in the U.S. is boosting the growth of the market.

The number of people diagnosed with cancer is expected to increase multi-fold in the coming eight years. Although survivors have increased considerably owing to research in the oncology field, the number of cancer patients is expected to increase across the world. Pancreatic cancer has a poor prognosis with a survival of only 1 to 3 years. Approximately 13 people are diagnosed with GI stromal tumors each day. More than 60, 000 new cases of renal cell carcinoma are diagnosed every year in the U.S. Hence, representing an increasing prevalence of cancer and the need for effective treatments against various types of cancer. Investment in R&D is expected to grow owing to the disease prevalence across the U.S. thereby boosting the industry’s growth.

The COVID-19 pandemic has halted new research projects and reallocated resources for other diseases. The supply chain for clinical trial samples has also been interrupted as a result of blocked borders. Hence, this market is disrupted. However, the COVID-19 response has resulted in new developments on the market that have transformed the conduct of clinical trials. Decentralized/virtual clinical trials are one such technique. Virtual trials have a very important role in the current COVID-19 scenario. As a result of the virtual visit and remote patient monitoring, participants have a choice and peace of mind to minimize risks. Monitoring gadgets, software tools, and mobile phones enable participants to complete the experiment from their homes.

Request a free sample copy or view the report summary: U.S. Clinical Trials Market Report

U.S. Clinical Trials Market Report Highlights

• Phase III dominated the market with a revenue share of 53.6% in 2021. These trials are more crucial as they involve 300 to 3000 participants and have a longer period of time. Thus, it is the most expensive phase
• The interventional segment accounted for the largest share of 46.0% in 2021
• Based on indication, the oncology segment is anticipated to exhibit the highest CAGR of 5.7% over the analysis timeframe. This growth is due to the growing number of cases of cancer. Thus, a large amount of expenditure is spent on oncology clinical trials

Access Press Release@ https://www.grandviewresearch.com/press-release/us-clinical-trials-market-analysis

U.S. Clinical Trials Market Segmentation

Grand View Research has segmented the U.S. Clinical Trials Market based on phase, study design, and indication:

U.S. Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Phase I
• Phase II
• Phase III
• Phase IV

U.S. Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 - 2030)

• Interventional Studies
• Observational Studies
• Expanded Access Studies

U.S. Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Autoimmune/Inflammation
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Osteoarthritis
  • Irritable Bowel Syndrome (IBS)
  • Others
• Pain Management
  • Chronic Pain
  • Acute Pain
• Oncology
  • Blood Cancer
  • Solid Tumors
  • Other
• CNS Conditions
  • Epilepsy
  • Parkinson’s Disease (PD)
  • Huntington’s Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle Regeneration
  • Others
• Diabetes
• Obesity
• Cardiovascular
• Others

List of Key Players in the U.S. Clinical Trials Market

• Parexel International Corp.
• IQVIA Holdings Inc.
• LabCorp
• Thermo Fisher Scientific (Pharmaceutical Product Development)
• Charles River Laboratory
• ICON plc
• Wuxi AppTec
• Eli Lilly and Company
• SGS SA
• Novo Nordisk A/S
• Clinipace
• Syneos Health Inc.
• Pfizer Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Dental Splint Market Outlook & Future Forecast Report Till 2030

 U.S. Dental Splint Market Growth & Trends

The U.S. dental splint market size is expected to reach USD 220.6 million by 2030, according to a new report by Grand View Research, Inc., The market is anticipated to expand at a CAGR of 6.1% from 2022 to 2030. It is widely accepted that oral health significantly affects overall health. Oral hygiene maintenance is equally as crucial as caring for other body components. People have just recently begun to realize how important keeping proper dental and oral hygiene is. For instance, more people are becoming aware of the function of the temporomandibular joint (TMJ) as well as other illnesses and possible treatments. The market for dental splints has expanded as a result.

In the United States, dentists are in charge of instructing their patients on how to properly prevent tooth decay, periodontal diseases, and other issues with oral health. The National Children's Dental Health Month, awareness program is sponsored by the American Dental Association in the United States in February to make parents and kids more conscious of the value of maintaining good oral health. The campaign's main goal is to educate young people on the value of routine teeth brushing and dental checkups to stave off dental issues.

After tension headaches and back pain, TMD pain is the third most common chronic pain disease globally. Because TMD pain can mirror other disorders, many TMD sufferers go misdiagnosed. Women are more prone than men to suffer from TMJ issues, and those who use oral contraceptives or more estrogen are more likely to seek treatment.

According to a recent study, between 11 and 12 million American adults suffer from temporomandibular joint pain. Women are twice as likely as males to get temporomandibular problems, especially if they are between the ages of 35 and 44. With a TMJ repositioning splint, one common treatment involves realigning the jaw into the right position. By cushioning your teeth, a dental splint can help with jaw alignment, ease face muscle strain, and improve jaw alignment. Hence, the demand for dental splints in the US will probably be driven by this.

The pandemic has decreased demand for dental supplies and equipment, which has had an impact on new investments in dental healthcare and education. Due to the product's disrupted supply chain and national lockdown regulations, sales and income for oral care items such as dental splints and mouth guards were also below average in the first half of 2020.

However, the market expanded significantly in 2021 as a result of the stress disorder linked to COVID-19. Dentistry was not exempt from the COVID-19 outbreak's impact on nearly every aspect of our way of life. Given that stress is one of the main causes of bruxism, the rise in cases over the previous two years is not surprising. Since the start of the COVID-19 epidemic, the majority of dental practitioners have observed a considerable increase in stress-related oral health conditions. This had a positive impact on the market for dental splints in 2021.

Request a free sample copy or view the report summary: U.S. Dental Splint Market Report

U.S. Dental Splint Market Report Highlights

• The rigid type of segment dominated the dental splint market in 2021, due to the rigid dental splints being more prominent in the market, for instance, Oral-B Nighttime Dental Guard by P&G. Hence, the presence of a major share of the rigid splints, makes it a dominant segment
• The offline (through dental professionals) segment is expected to witness a significant CAGR of 5.3% during the forecast period. The dominance is due to the preference of patients to get recommendations from dentists and buy the products. However, online sale is becoming very popular as many companies are offering a direct online sale to their customers, hence likely to grow at a faster rate
• Key market players include Aqualizer, Glidewell, Procter & Gamble, Dentek, Brux Night Guard, Sporting Smiles, Smile Brilliant, Chomper Labs, and Sentinel Mouth Guards

Access Press Release@ https://www.grandviewresearch.com/press-release/us-dental-splint-market-analysis

U.S. Dental Splint Market Segmentation

Grand View Research has segmented the U.S. dental splint market based on mobility degree and distribution channel:

U.S. Dental Splint Mobility Degree Outlook (Revenue, USD Million, 2018 - 2030)

• Flexible
• Semi-rigid
• Rigid

U.S. Dental Splint Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Offline (Through dental professionals)
• Online

List of Key Players in the U.S. Dental Splint Market

• Aqualizer
• Glidewell
• Procter & Gamble
• Dentek
• Brux Night Guard
• Sporting Smiles
• Smile Brilliant
• Chomper Labs
• Sentinel Mouth Guards

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Washing Machine Parts Market 2030 Analysis By Leading Players, Types, Growth Factors, Demand, Opportunities, Current Trends & Predictions

 U.S. Washing Machine Parts Market Growth & Trends

The U.S. washing machine parts market size is expected to reach USD 6.33 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 4.3% from 2022 to 2030. This growth can be attributed to the upgrading lifestyle, and growth in disposable income coupled with rapid industrialization.

A recent trend is the use of technology to create washing machine parts that consume less water and energy. The U.S. market for washing machine parts is expanding as a result of changing lifestyles, rising disposable income, and the availability of cutting-edge technologies. Offline distribution channel is the dominant distribution channel in the U.S. washing machine parts industry. The offline medium enforces manufacturers and suppliers to introduce efficient marketing strategies.

The market is expected to witness growth over the forecast period owing to the increasing investments by foreign producers and global players. The U.S. is experiencing high economic growth. The spending power of the population in the U.S. is increasing. The consumer goods sector, which includes washing machines, is expected to grow over the forecast period. The continuous growth of the population is also positively impacting the consumer goods sector.

In the case of indirect distribution of machine parts, a manufacturer might choose to distribute its products through a short channel with few middlemen or through a long channel with many middlemen. The offline distribution channel is the shortest channel that a manufacturer opts to make its products & services available to customers. Manufacturers sell their products through third-party suppliers, retail stores, chain stores, and direct selling. Manufacturers and suppliers can increase the product reach through an optimum marketing strategy and reasonable pricing.

The apparel industry in the U.S. is exposed to constant upgrades and innovations in fabrics among other factors. To cater to the new and upgraded fabrics, the U.S. washing machine industry has to develop products that can handle the way these fabrics are being washed and dried without affecting their quality. This depends upon the way the fabric reacts to the agitator and drum of the machine while being washed. Hence, the development of smart washing machines with optimum parts is becoming prevalent to meet the demands of various existing and new textiles during the cleaning process. This is propelling the need to develop smart washing machine parts.

The online distribution channel is gaining importance in the U.S. due to the growing inclination of the population toward online shopping post-pandemic. The consumer gets to choose from a variety of brands’ products and services and price ranges depending upon the specific part that needs to be repaired or replaced. To cater to consumer demand, manufacturers and suppliers of cleaning appliance parts in the U.S. are establishing new online products and service-providing portals.

The prominent companies serving across the U.S. are focused on providing efficient product lines to be competent in the global market. Players like Beko U.S., Inc.; LG Electronics; Jenfab Cleaning Solutions; and Whirlpool Corporation are investing in R&D to facilitate new technologies to provide smart washing parts.

Request a free sample copy or view report summary: U.S. Washing Machine Parts Market Report

U.S. Washing Machine Parts Market Report Highlights

• Online segment is growing at a CAGR of 4.2%, attributed to the increased digitalization. Consumers from remote areas and lesser accessible areas that do not house offline mediums of product sale can access the websites and online delivery portals to acquire the desired product through online mediums
• Offline distribution channel led the industry with a share of 90.8% in 2021. Manufacturers plan to offer their goods to clients directly or indirectly. It is a direct-to-consumer strategy, and the manufacturer completely controls the distribution process
• Offline distribution channel includes selling at the plant, door-to-door sales, service centers, wholesalers, and opening own selling outlets. The U.S. washing machine parts are readily available in offline mode
• The rise in the population in the U.S. and the migration of people from villages to cities has increased the need for washing appliances and the development of parts that meet the demand for the modern washing machine industry

Access Press Release@ https://www.grandviewresearch.com/press-release/us-washing-machine-parts-market-analysis

U.S. Washing Machine Parts Market Segmentation

Grand View Research has segmented the U.S. washing machine parts market based on distribution channel:

U.S. Washing Machine Parts Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Online
• Offline

List of Key Players in the U.S. Washing Machine Parts Market

• Beko U.S., Inc.
• LG Electronics
• com.
• Sundberg America, Inc.,
• Jenfab Cleaning Solutions,
• Alliance Laundry Systems LLC,
• com,
• GE Appliances,
• Whirlpool Corporation
• Kellett Enterprises, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Personalized Medicine Biomarkers Market is Expected to Enhance USD 43.07 Billion Revenue By 2030: Grand View Research Inc.

 Personalized Medicine Biomarkers Market Growth & Trends

The global personalized medicine biomarkers market size is expected to reach USD 43.07 billion by 2030, expanding at a CAGR of 15.51% from 2022 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the rising awareness, importance of predicting prognosis, and selection of dose. Moreover, personalized medicine biomarkers serve as an essential tool for the selection of patients and providing the right treatment to the right patient further propelling the demand for personalized medicine biomarkers.

Biomarkers are unique analytes that can be utilized to improve diagnosis forecast treatment outcomes and direct treatment decisions. They are crucial to personalized medicine. The increased usage of biomarkers to enhance patient outcomes is popular in clinical trials, and its use in clinical practice is expanding quickly. The development of personalized medicines using biomarkers is expected to create effective and safe therapies for every patient. This is a major relief for patients at advanced stages of chronic diseases like cancer, which further drives the market growth. For instance, in August 2022, VENTANA MMR RxDx Panel, an FDA approved first IHC-based assay used for the identification of patients with advanced cancer that is Pembrolizumab treatment eligible.

Early detection/screening biomarkers predict the outcome of disease in patient population prior to therapy. It can also help enrich clinical trials by helping choose patients more likely to respond to treatment. For instance, Oncotype Dx is a diagnostic test developed by Genomic Health, Inc. This test examines 21 genes and helps predict the likelihood of reoccurrence of breast cancer in a patient after initial treatment. In April 2022, updated ASCO guidelines recommended the usage of the Oncotype DX test for breast cancer patients at early stages to guide treatment decisions.

Moreover, biomarkers are used for their predictive and prognostic utility that helps predict the occurrence of a health condition. For instance, the prostate-specific antigen is used to predict the survival of patients with prostate cancer. CRP is used to predict disease-free survival in breast cancer and as a risk factor in cardiovascular disorders. Serum LDH helps predict survival in case of metastatic brain tumors. Similarly, CA125 helps predict metastatic diseases in patients with uterine carcinoma.

Furthermore, key players operating in the personalized medicine biomarkers industry are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in October 2021, Agilent Technologies Inc. received FDA approval for Agilent Ki-67 IHC MIB-1 pharmDx (Dako Omnis), for the identification of patients with a high risk of breast cancer recurrence.

Request a free sample copy or view report summary: Personalized Medicine Biomarkers Market Report

Personalized Medicine Biomarkers Market Report Highlights

• Early detection/screening segment is expected to grow at the fastest CAGR owing to the need to provide early treatment to patients
• Oncology segment held the largest market share in 2021 owing to the rising prevalence of cancer and the wide availability of FDA-approved personalized biomarkers tests for cancer
• North America held the largest market share attributable to the presence of improved healthcare infrastructure, rising prevalence of target diseases, and increasing government funding for innovation in biomarkers

Access Press Release@ https://www.grandviewresearch.com/press-release/global-personalized-medicine-biomarkers-market

Personalized Medicine Biomarkers Market Segmentation

Grand View Research has segmented the global personalized medicine biomarkers market based on application, indication, and region:

Personalized Medicine Biomarkers Application Outlook (Revenue, USD Million, 2018 - 2030)

• Early Detection/Screening
• Diagnosis
• Treatment Selection
• Monitoring

Personalized Medicine Biomarkers Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
  • By Type
    • Breast Cancer
    • Lung Cancer
    • Colon Cancer
    • Others
  • By Circulating Biomarkers
    • Circulating Tumor Cells (CTCs)
    • Circulating Cell-free DNA (cfDNA)
    • Extracellular Vesicles (EVs)
    • Other Circulating Biomarkers
  • Neurology
  • Diabetes
  • Autoimmune Diseases
  • Cardiology
  • Others

Personalized Medicine Biomarkers Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Personalized Medicine Biomarkers Market

• Laboratory Corporation of America Holding
• Quest Diagnostics Incorporated
• Agilent Technologies, Inc.
• Genome Medical, Inc.
• Coriell Life Sciences.
• Thermo Fisher Scientific Inc.
• NeoGenomics Laboratories
• FOUNDATION MEDICINE, INC.
• Illumina, Inc.
• Guardant Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Passwordless Authentication Market Strong Application and Emerging Trends also Scope by 2030: Grand View Research Inc.

 Passwordless Authentication Market Growth & Trends

The global passwordless authentication market size is expected to reach USD 55.70 billion by 2030, growing at promising 18.2% CAGR, according to a new report by Grand View Research, Inc. Passwordless authentication is a security procedure that uses unique biological traits of a person to validate their authenticity. The increasing adoption of smartphones and other electronic gadgets is a crucial element driving the biometric authentication market forward.

According to a July 2022 Oxford Economics and Samsung study, up to 85% of small and midsize enterprises allow all or most of their staff to use mobile devices for work. Personal laptops and smartphones used by employees might expose a small firm to the dangers of unauthorized access to proprietary data, files, and systems. Such solutions remain the need of the hour and growing focus of many companies around the world.

For instance, in September 2022, AaDya Security, a cyber-security firm, announced the availability of passwordless authentication for Judy, the first all-in-one cybersecurity solution for SMEs. The new security feature protects how small business employees access company resources, mainly when they operate remotely and on mobile phones and personal laptops.

The growing requirement for an additional layer of protection beyond passwords fuels the growth of the passwordless authentication industry. To authenticate identities, fingerprint sensors and smartcards are utilized, and these security points allow for a seamless experience and data flow across locations. Most businesses are using voice biometric authentication in their workplaces for their personnel.

Reduced fraud exposure and lower authentication costs often drive organizations to implement voice biometric technology in their facilities. For instance, in July 2022, Turant Inc., a voice biometric AI firm, launched its cutting-edge AI solution in India. The company seeks to eliminate OTP-related fraud in transactions across use cases across business/industry domains, including e-commerce deliveries, by making it available in all Indian languages and roughly 20,000 dialects.

Furthermore, due to the increasing number of incidences of data theft around the world, passwordless authentication has gained popularity. Data theft issues in devices such as computers, cellphones, and tablets have increased the requirement for protection beyond passwords. fingerprint sensors and facial recognition are ways modern gadgets can be secured to prevent data theft.

For instance, in August 2022, ForgeRock, an international identity and access management software business, established strategic cooperation with Israeli software company Secret Double Octopus. ForgeRock will use SDO technology to provide employees, contractors, and vendors with a unified multi-factor secure experience. ForgeRock Enterprise Connect, the new solution, connects effortlessly with any ForgeRock deployment option, allowing organizations to gain increased security for databases, workstations, VPNs, and servers.

Request a free sample copy or view report summary: Passwordless Authentication Market Report

Passwordless Authentication Market Report Highlights

• Growing investments in developed countries such as the U.S., Canada, Germany, France, and the U.K. for implementing passwordless authentication technology is a crucial factor driving the growth
• Fingerprint recognition and facial recognition provide various benefits. The increased security, accountability, convenience, and their non-transferable nature are crucial drivers for the growth
• The surge in e-commerceand internet banking, as well as legislations by various authorities such as central banks mandates large organizations to utilize robust authentication mechanisms to authenticate customers
• Multi-factor authentication protects clients from phishing attempts and fraudulent purchases and secures transactions

Access Press Release@ https://www.grandviewresearch.com/press-release/global-passwordless-authentication-market

Passwordless Authentication Market Segmentation

Grand View Research has segmented the global passwordless authentication market based on component, product type, authentication type, portability, end-user, and region:

Passwordless Authentication Component Outlook (Revenue, USD Million, 2017 - 2030)

• Hardware
• Software
• Services

Passwordless Authentication Product Type Outlook (Revenue, USD Million, 2017 - 2030)

• Fingerprint Authentication
• Palm Recognition
• Iris Recognition
• Face Recognition
• Voice Recognition
• Smart Card
• Others

Passwordless Authentication Type Outlook (Revenue, USD Million, 2017 - 2030)

• Single-factor Authentication
• Multi-factor Authentication

Passwordless Authentication Portability Outlook (Revenue, USD Million, 2017 - 2030)

• Fixed
• Mobile

Passwordless Authentication End-user Outlook (Revenue, USD Million, 2017 - 2030)

• IT & Telecom
• Retail
• Transportation & Logistics
• Aerospace & Defense
• BFSI
• Healthcare
• Government
• Others

Passwordless Authentication Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East and Africa (MEA)

List of Key Players in the Passwordless Authentication Market

• ASSA ABLOY
• DERMALOG Identification Systems GmbH
• East Shore Technology, LLC
• Fujitsu
• HID Global Corporation
• M2SYS Technology
• Microsoft
• NEC Corporation
• Safran
• Thales

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

DNA Methylation Market To Hold a High Potential for Growth by 2030: Grand View Research Inc.

 DNA Methylation Market Growth & Trends

The global DNA methylation market size is expected to reach USD 4.22 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 14.67% from 2022 to 2030, due to the increased usage of DNA methylation in sequencing analysis. The increased adoption of DNA methylation in the agrigenomics field remains a promising driver of this growth.

In January 2020, a research journal published in Springer stated that DNA methylation and expression analysis shows peanut foliar disease resistance genes have epialleles. DNA methylation analysis continues to open new doors of opportunities for researchers, and pharmaceutical companies. Increased research and developments in this field would further drive the DNA methylation industry in the coming years.

Furthermore, the growing prevalence of esophageal adenocarcinoma has contributed to the overall growth. According to the data published by the American Cancer Society (ACS), in 2022, an estimated 20,640 esophageal cancer cases were undiagnosed in the U.S. The chronic disease. resulted in 16,410 deaths.

Growing esophageal cancer cases in the U.S. highlight the urgent need for early intervention measures that can help improve the low survival rates for patients. In October 2022, a research article published by Fred Hutchinson Cancer Center stated that methylated DNA biomarkers could be used for the detection of esophageal adenocarcinoma and high-grade dysplasia.

The significant increase in the adoption of epigenetics-based treatment strategies, coupled with the broad nucleic acid-based diagnostic tests & kits commercialization is projected to drive the growth of the market. In May 2022, an article published in PubMed stated that theepigenetics-based treatment strategies are to be used for studying Alzheimer’s disease. However, a lack of expertise to perform DNA methylation experiments could restrict the growth. DNA methylation holds significant potential in various biotechnology applications, while the relatively low number of skilled professionals remains an obstacle to growth.

Key players operating in the market are taking several initiatives such as new product developments, entering into a strategic alliance, and regional expansion among others. For instance, in May 2022, Oxford Nanopore announced integrating Remora, a technique that offers accurate and real-time epigenetic insights with nanopore sequencing software. This would further offer simple access to accurate whole genome methylation detection. Similarly, in June 2020, Base Genomics announced of advancing and developing its DNA methylation technology. the aim is to sequence a large amount of epigenetic data from a blood test which could revolutionize the preventative medicine arena.

Request a free sample copy or view report summary: DNA Methylation Market Report

DNA Methylation Market Report Highlights

• The overall growth is attributed to the growing adoption of DNA methylation in sequencing analysis in the molecular biology and genomics and agrigenomics fields
• By technology, the sequencing segment captured the highest share in 2021, owing to the increasing adoption of sequencing technology for research purposes by numerous market players
• By product, the consumables segment dominated the market as it is majorly used in the DNA sequencing procedures and diagnosis process
• By application, the clinical research segment dominated the market due to the rising number of clinical trials for various diseases globally, and constant government support leading to increasing R&D expenditure
• By end use, pharmaceutical and biotechnology companies dominated the market, thanks to the increasing usage of high throughput technologies such as NGS by key market players
• North America dominated the market in 2021 due to the wide network of manufacturing and R&D facilities. The growing number of product launches, FDA approvals, and the presence of key market players remains a promising driver of growth in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dna-methylation-market

DNA Methylation Market Segmentation

Grand View Research has segmented the global DNA methylation market based on technology, product, application, end-use, and region:

DNA Methylation Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Polymerase Chain Reaction (PCR)
• Microarray
• Sequencing
• Others

DNA Methylation Product Outlook (Revenue, USD Million, 2018 - 2030)

• Consumables
• Kits & Reagents
• Enzymes
• Instruments & Software

DNA Methylation Application Outlook (Revenue, USD Million, 2018 - 2030)

• Gene therapy
• Clinical Research
• Diagnostics
• Others

DNA Methylation End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research & Academia

DNA Methylation Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of DNA Methylation Market

• New England Biolabs
• Sysmex Corporation
• Abcam plc.
• Hoffmann-La Roche Ltd.
• Diagenode Diagnostics S.A.
• Thermo-Fisher Scientific Inc.
• Agilent Technologies Inc.
• BioRad Laboratories Inc.
• Exact Sciences Corporation
• QIAGEN N.V.
• Active Motif, Inc.
• Illumina Inc.
• EpiGentek Group Inc.
• Pacific Biosciences Inc.
• New England Biolabs Inc.
• Merck KGaA
• Zymo Research Corporation
• PerkinElmer Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Plywood Market Expected to Receive Greater Traction As Manufacturers’ Contribution Swells

 U.S. Plywood Market Growth & Trends

The U.S. plywood market size is expected to reach USD 15.59 billion by 2030, according to Grand View Research, Inc. It is anticipated to expand at a CAGR of -1.9% from 2022 to 2030. The growth is positively impacted by the growth of the organized retail segment, including super-market, hyper-markets, and departmental stores, which also contributed to the growth of commercial buildings.

The construction industry in the U.S. has been a significant contributor to the country’s growth and development of construction and real estate industries had been growing consistently till the outbreak of COVID-19. However, post the outbreak, the global economic flow was disrupted. Hence, to revive the market, several construction projects were launched in 2021 and 2022.

Refurbishment includes renovation and remodeling of old buildings to make them energy-efficient, visually pleasing, and sustainable. In this process, maintenance, replacement, and repair of buildings and building components are made to give the structure a longer life. This involves changing of windows & doors, structural alterations & modifications, and making the structure aesthetically more pleasing.

The real estate market in the U.S. is already more developed compared to most countries. The lifespan of a building ranges from 31 to 50 years after its completion; hence, once the structure becomes old, its quality and strength are compromised. If such buildings are not put through regular maintenance and care, they prove to be a threat to the residents. Hence, the majority of old buildings are renovated and refurbished regularly to ensure a longer life and safety of the inhabitants. This is triggering the demand for plywood in the construction sector and contributing to the growth of plywood in the U.S.

The refurbishment has become a common practice in urban areas due to changing consumer tastes and market trends and increasing disposable income. The people are actively investing and reinvesting to modify their places of work and business to please the customers and keep up with varying customer tastes. The increasing rate of fire accidents and electrical mishaps is also responsible for increased refurbishment within the region, along with the demand for plywood in the U.S.

Since the outbreak of COVID-19, there has been disruption along the supply lines, which has resulted in price fluctuations in the U.S. market. The prices of wood and adhesives have been increasing over the last year, due to which the cost of manufacturing plywood has increased. However, it is expected that prices to come down and reach the pre-pandemic level over the forecast period.

The U.S. plywood industry is fragmented by the presence of large-, medium-, and small-sized players. The plywood quality and price differentiation among market players are low, which results in plywood manufacturers striving for higher market dominance. This can result in intense competitive rivalry among vendors. Moreover, with growing investments in the refurbishment of commercial structures, the market rivalry is expected to increase over the forecast period.

Request a free sample copy or view report summary: U.S.Plywood Market Report

U.S. Plywood Market Report Highlights

• The structural application segment accounted for 68.6% of the revenue share in 2021 due to its application for sheathing, bracing for roofs and floors, storage decks, hoardings, packing crates, outdoor furniture, and playing equipment
• The furniture segment of the non-structural segment accounted for the largest revenue share of 40.5% in 2021. This is attributed to the U.S. furniture manufacturing industry is one of the major markets for hardwood plywood
• The residential segment in the U.S. is expected to account for 64.6% of the total revenue share by 2030. This is due to the growing applications of plywood in residential constructions for furniture, interiors, and modifications
• The commercial segment in the U.S. accounts for 33.8% of the revenue share in 2021. The increasing number of new commercial buildings in the U.S. is expected to drive the demand over the coming years
• The Southern region is expected to reach 55.5% of the total revenue share in 2021, as the big economies such as Texas, Virginia, Florida, and Georgia witness an increase in population along with a high standard of living

Access Press Release@ https://www.grandviewresearch.com/press-release/us-plywood-market-analysis

U.S. Plywood Market Segmentation

Grand View Research has segmented the U.S. plywood market based on end-use, application, and region:

U.S. Plywood End-use Outlook (Volume, Thousand Cubic Meters; Revenue, USD Million, 2017 - 2030)

• Residential
• Commercial

U.S. Plywood Application Outlook (Volume, Thousand Cubic Meters; Revenue, USD Million, 2017 - 2030)

• Structural
• Non-Structural
  • Furniture
  • Kitchen Cabinet
  • Flooring
  • Container Floor
  • Others

U.S. Plywood Regional Outlook (Volume, Thousand Cubic Meters; Revenue, USD Million, 2017 - 2030)

• Northeast
• Midwest
• South
• West

List of Key Players in the U.S. Plywood Market

• Georgia Pacific
• PotlatchDeltic Corporation
• Weyerhaeuser Company Ltd.
• Boise Cascade Company
• Roseburg Forest Products
• West Fraser
• Columbia Forest Products
• RoyOMartin
• Timber Products Company
• Coastal
• Hood Industry
• BlueLinx
• South Coast Lumber Co. & Affiliates

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Arterial Cannula Market to Undertake Strapping Growth By 2030

 Arterial Cannula Market Growth & Trends

The global arterial cannula market size is projected to reach USD 33.4 million by 2030, registering a CAGR of 7.2% over theforecast period, according to a new report by Grand View Research. An increase in the prevalence of chronic diseases is leading to a rise in surgical procedures, which is driving the growth of the industry. According to an article published by the National Library of Medicine in September 2020, an overwhelming 310 million major surgeries are performed each year; around 20 million in Europe and about 40 to 50 million in the USA. Furthermore, advancements in minimally invasive surgeries are driving product demand. Minimally invasive techniques and cutting-edge technology give patients fast recovery time, less pain, and the best aesthetic results.

These advantages have resulted in the increasing adoption of minimally invasive techniques, which is leading to an increasing number of patients opting to undergo these surgical interventions. The COVID-19 pandemic resulted in a temporary fall in product sales. This is due to the postponement of elective surgeries to avoid the spread of the virus and focus dedicatedly on combatting the COVID-19 virus. However, the market began to quickly recover in the second half of the pandemic with increasing efforts of healthcare professionals and different strategies led down at the micro as well as macro-economic levels. The industry is further expected to experience significant demand over the forecast period with governments of various countries majorly focusing on healthcare to avoid similar situations in the future. Moreover, increasing investments in the healthcare sector are also expected to boost the overall industry growth over the forecast period.

Request a free sample copy or view report summary: Arterial Cannula Market Report

Arterial Cannula Market Report Highlights

• The ECMO segment held the highest revenue share in 2022 owing to the increasing adoption of the arterial cannula for oxygenation
• The cardiopulmonary bypass surgery segment is projected to experience the fastestCAGR over the forecast period due to the increasing prevalence of cardiac diseases
• The 20-22 Fr size segment led the market, in terms ofrevenue share in 2022 as these are the most commonly used arterial cannulas
• The hospitals segment held the largest share in 2022 as the majority of surgical procedures are carried out in these settings
• The ASCs segmentwill registerthe fastest growth rate over the forecast period due to favorable reimbursement initiatives by various governments
• North America was the largest region in 2022 owing to a well-developed healthcare structure and a significant patient pool
• Asia Pacific is expected to be the fastest-growing region over the forecast period due to the high prevalence of chronic diseases and the increasing geriatric population

Access Press Release@ https://www.grandviewresearch.com/press-release/global-arterial-cannula-market

Arterial Cannula Market Segmentation

Grand View Research has segmented the global arterial cannula market based on application, size, end-use, and region:

Arterial Cannula Application Outlook (Revenue, USD Million, 2017 - 2030)

• Cardiopulmonary Bypass Surgery
• Extracorporeal Membrane Oxygenation (ECMO)
• Others

Arterial Cannula Size Outlook (Revenue in USD Million, 2017 - 2030)

• 14-16 Fr
• 17-19 Fr
• 20-22 Fr
• 23-25 Fr
• 26-28 Fr
• 29- 31 Fr
• 32-34 Fr
• 35-36 Fr

Arterial Cannula End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Ambulatory Surgical Centers
• Others

Arterial Cannula Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Arterial Cannula Market

• Medtronic, plc.
• LivaNova plc
• Edward Lifesciences
• Getinge AB
• Fresenius Medical Care
• BD
• Nipro Corp.
• Andocor
• Freelife Medical GmbH
• Surgical Holdings
• Kangxin Medical

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Specimen Collection Cards Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development 2030

 Specimen Collection Cards Market Growth & Trends

The global specimen collection cards market size is expected to reach USD 621.29 million by 2030, growing at 4.9% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to register promising growth owing to the increasing emphasis on non-invasive procedures, favorable government policies for newborn screening, and increasing investments in research & development. Moreover, ease of use and cost-effectiveness of the products is also likely to have a positive impact on the market growth.

The market is experiencing significant growth due to the increasing focus on personalized medicine, genetic testing, health monitoring, and well-being initiatives. Personalized medicine aims to customize medical treatments based on individual genetic profiles, lifestyle factors, and other relevant information. Genetic testing plays a vital role in this approach by providing insights into an individual's genetic makeup, enabling personalized diagnostics, treatment selection, and disease prevention strategies. Specimen collection cards have become essential tools in genetic testing processes, offering a convenient and reliable method for collecting various biological samples, such as saliva, blood, and tissue.

Moreover, specimen collection cards contribute to health monitoring and well-being programs by enabling the collection of biomarkers & analytes that provide valuable information about an individual's health status and overall well-being. These cards are used in kits designed for monitoring hormone levels, detecting infectious diseases, and measuring key biomarkers related to chronic conditions like diabetes or cardiovascular diseases.

The ease of sample collection using specimen collection cards promotes regular monitoring, facilitating early detection of health issues and timely interventions, ultimately leading to improved health outcomes. The growing emphasis on personalized medicine, genetic testing, health monitoring, and well-being initiatives is driving the demand for specimen collection cards in the market. These cards provide a practical solution by offering a versatile and user-friendly platform for collecting various biological samples, empowering individuals to take control of their health. The integration of specimen collection cards into innovative genetic testing kits and health monitoring solutions further solidifies their role in supporting personalized medicine and enabling individuals to make well-informed decisions about their health & well-being.

Key players operating in the industry are focusing on raising funds to excel in their research and development activities along with other inorganic and organic strategies. For instance, in June 2022, OrisDX received funding for its innovation in saliva-based diagnostics for oral cancers. The company received funding of USD 1.76 million as an investment for progressing its research. Such developments are estimated to offer a favorable environment for the adoption of specimen collection cards during the forecast period.

Request a free sample copy or view report summary: Specimen Collection Cards Market Report

Specimen Collection Cards Market Report Highlights

• The specimen collection cards industry is expected to witness considerable growth due to rising emphasis on personalized medicines and cost-efficiency
• The blood sample segment held the largest share in 2022, owing to an extensive rate of newborn screening in developed as well as developing countries
• In 2022, the cotton & cellulose-based segment dominated the material segment owing to its operational superiority over other materials. Furthermore, the improved capacity of cotton & cellulose-based material for sample storage and integrity also drives its growth
• The Whatman 903 product segment dominated the market in 2022 owing to its adoption in various government initiatives and research studies. Moreover, the extensive geographical presence of the company is also playing a major role in dominating market share
• The newborn screening segment dominated the application segment in 2022. The favorable regulatory environment for newborn screening in several countries is contributing to the segment growth
• The offline segment dominated the market in 2022 owing to convenient access. The online segment is estimated to register the fastest CAGR due to technological advancements
• The hospital and clinics end-use segment held the major market share in 2022 due to its substantial adoption
• North America dominated the market in 2022 due to the presence of key players and rising support from the government

Access Press Release@ https://www.grandviewresearch.com/press-release/global-specimen-collection-cards-market

Specimen Collection Cards Market Segmentation

Grand View Research has segmented the global specimen collection cards market based on type of specimen, product, material, application, distribution channel, end-use, and region:

Specimen Collection Cards Type Of Specimen Outlook (Revenue, USD Million, 2018 - 2030)

• Blood
• Saliva
• Urine
• Buccal Cells
• Others

Specimen Collection Cards Material Outlook (Revenue, USD Million, 2018 - 2030)

• Cotton & Cellulose-based
• Fiber-based
• Others

Specimen Collection Cards Product Outlook (Revenue, USD Million, 2018 - 2030)

• Whatman 903
• Ahlstrom 226
• FTA
• Others

Specimen Collection Cards Application Outlook (Revenue, USD Million, 2018 - 2030)

• New Born Screening (NBS)
• Infectious Diseases Testing
• Therapeutic Drug Monitoring
• Forensics
• Research
• Wellbeing/Health Monitoring
• Other Applications

Specimen Collection Cards Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online
• Offline

Specimen Collection Cards End-use Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics
• Diagnostics Centers
• Others

Specimen Collection Cards Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Specimen Collection Cards Market

• QIAGEN
• PerkinElmer Inc.
• DBS System SA
• Danaher Corporation
• Eastern Business Forms, Inc.
• Ahlstrom
• ARCHIMED Life Science GmbH
• GenTegra LLC
• FortiusBio
• CENTOGENE N.V.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.